Table 2 Median overall survival (MOS)* for female breast cancer patients

Group factors

All Patients

976178

14.75

14.69

14.84

Demographic

Age (Years)

18-49

252080

>14.99

N/A

N/A

50-64

354102

>14.99

14.94

N/A

65-74

192042

13.59

13.48

13.73

≥75

177954

7.14

7.1

7.18

Race

White

851863

14.77

14.71

14.86

Black

98641

13.25

13.03

13.66

Others

25674

>14.95

N/A

N/A

Education (%), did not graduate from high school

≥29

144440

13.5

13.35

13.74

20-28

202583

14.09

13.95

14.16

14-19

217587

14.49

14.37

14.64

<14

366118

14.92

14.9

N/A

Clinical characteristic

Stage

Stage I

468222

14.99

14.92

N/A

Stage II

361618

14.78

14.69

14.94

Stage III

101260

7.81

7.7

7.91

Stage IV

45078

1.7

1.67

1.73

Charlson Comorbidity

0

375270

10.33

10.16

N/A

1

41661

9.6

9.45

9.85

≥2

8322

5.58

5.4

5.81

Unknown

550925

14.71

14.67

14.8

Access to health care

Payer Status

Uninsured

24849

>14.89

14.06

N/A

Private

542805

15

N/A

N/A

Medicaid

41718

13.08

12.84

13.85

Medicare

334182

10.13

10.08

10.18

Unknown

32624

14.56

14.31

N/A

Income ($1000)

<30

117919

12.77

12.65

12.92

30-34

158762

13.92

13.79

14.05

35-45

256013

14.47

14.33

14.51

≥46

398086

14.92

14.9

N/A

Distance Travelled (Miles)

<10

556476

14.58

14.47

14.66

10-24

234049

15

N/A

N/A

25-49

88994

14.77

14.63

N/A

50-99

39053

>14.94

14.64

N/A

≥100

22349

14.99

N/A

N/A

Cancer Program

Community

110174

13.72

13.56

13.83

Comprehensive

563299

14.75

14.69

14.86

Academic Research

261484

>14.99

14.9

N/A

Others

41221

12.49

12.19

13.12

Diagnosing/Treating Facility

Same

662498

14.61

14.5

14.67

Different

313680

14.91

14.86

N/A

Treatment Delay (Days)

0-5

296904

14.76

14.69

14.92

6-20

284321

14.86

14.77

N/A

21-30

155774

14.84

14.67

N/A

≥31

193455

14.45

14.24

14.7